These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39415300)

  • 21. Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity.
    Wiąk-Walerowicz K; Wielosz E
    Reumatologia; 2024; 62(1):64-69. PubMed ID: 38558891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
    Kilic G; Kilic E; Ozgocmen S
    Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: Data from the SPACE cohort.
    Rubio Vargas R; van den Berg R; van Lunteren M; Ez-Zaitouni Z; Bakker PA; Dagfinrud H; Ramonda R; Landewé R; Molenaar E; van Gaalen FA; van der Heijde D
    RMD Open; 2016; 2(1):e000283. PubMed ID: 27403336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
    Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients.
    Pike J; Dong Y; Piercy J; Booth N; Holdsworth E; Hunter T
    Rheumatol Ther; 2021 Jun; 8(2):849-862. PubMed ID: 33864593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
    Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
    Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the clinical characteristics and quality of life of male and female patients with non-radiographic axial spondyloarthritis.
    Unal Enginar A
    Int Immunopharmacol; 2023 Oct; 123():110627. PubMed ID: 37494835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of patient and disease characteristics on global functioning in patients with axial spondyloarthritis in routine care.
    Kiltz U; Wiatr T; Redeker I; Baraliakos X; Fedorov K; Braun J
    Semin Arthritis Rheum; 2022 Aug; 55():152006. PubMed ID: 35472664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Both ASDAS and ADC are associated with spinal mobility in active axial spondyloarthritis: A comparison between early and later disease.
    Chung HY; Chan SCW; Lee KH; Tsang HHL; Ng LL; Lau CS
    Int J Rheum Dis; 2022 Mar; 25(3):317-326. PubMed ID: 35019230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study.
    Regierer AC; Weiß A; Kiltz U; Sieper J; Schwarze I; Bohl-Bühler M; Kellner H; Poddubnyy D; Zink A; Braun J; Listing J; Strangfeld A
    J Rheumatol; 2023 Feb; 50(2):185-191. PubMed ID: 35914790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upadacitinib for axial spondyloarthritis: a meta-analysis of efficacy and safety.
    Tang H; Liu X; Zhao J; Tang Z; Zheng Z; Bai W
    Clin Rheumatol; 2024 Aug; 43(8):2391-2402. PubMed ID: 38874670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global Functioning in Axial Spondyloarthritis is Stronger Associated With Disease Activity and Function Than With Mobility and Radiographic Damage.
    Kiefer D; Braun J; Kiltz U; Chatzistefanidi V; Adolf D; Schwarze I; Kabelitz M; Lange U; Brandt-Jürgens J; Stemmler E; Sartingen S; Baraliakos X
    Arthritis Care Res (Hoboken); 2023 Jul; ():. PubMed ID: 37489291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice.
    Kumthekar A; Sanghavi N; Natu A; Danve A
    Curr Rheumatol Rep; 2024 May; 26(5):170-177. PubMed ID: 38372873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis.
    Osterhaus JT; Purcaru O
    Arthritis Res Ther; 2014 Aug; 16(4):R164. PubMed ID: 25099160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construct Validity of the Routine Assessment of Patient Index Data 3 (RAPID3) in the Evaluation of Axial Spondyloarthritis.
    García-Valle A; Andrés-de Llano JM; Fariña-González AJ; González-Benítez RD; Queiro-Silva R
    J Rheumatol; 2022 Jan; 49(1):36-43. PubMed ID: 34266987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Metrology in Axial Spondyloarthritis: Does It Provide Unique Information in Assessing Patients and Predicting Outcome? Results From the British Society for Rheumatology Biologic Register for Ankylosing Spondylitis.
    Biallas RL; Dean LE; Davidson L; Hollick R; Pathan E; Robertson L; Jones GT; Macfarlane GJ; Rotariu O
    Arthritis Care Res (Hoboken); 2022 Apr; 74(4):665-674. PubMed ID: 33140891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatigue in patients with spondyloarthritis associates with disease activity, quality of life and inflammatory bowel symptoms.
    Stebbings SM; Treharne GJ; Jenks K; Highton J
    Clin Rheumatol; 2014; 33(10):1467-74. PubMed ID: 24322832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
    Michielsens C; Bolhuis TE; van Gaalen FA; van den Hoogen F; Verhoef LM; den Broeder N; den Broeder AA
    Scand J Rheumatol; 2024 May; 53(3):180-187. PubMed ID: 37339375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort.
    Redeker I; Landewé R; van der Heijde D; Ramiro S; Boonen A; Dougados M; Braun J; Kiltz U
    RMD Open; 2023 Dec; 9(4):. PubMed ID: 38123481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.